SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-49518"
 

Search: onr:"swepub:oai:DiVA.org:oru-49518" > Expression of topoi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells

Uggla, Bertil, 1962- (author)
Department of Medicine, Örebro Medical Center Hospital, Örebro, Sweden
Möllgård, Lars (author)
Karolinska Institutet
Ståhl, Elisabeth (author)
Department of Pathology, Örebro Medical Center Hospital, Örebro, Sweden
show more...
Mossberg, Lise-Lott Mossberg (author)
Department of Pathology, Örebro Medical Center Hospital, Örebro, Sweden
Karlsson, Mats G., 1960- (author)
Department of Pathology, Örebro Medical Center Hospital, Örebro, Sweden
Paul, Christer (author)
Karolinska Institutet
Tidefelt, Ulf, 1951- (author)
Department of Medicine, Örebro Medical Center Hospital, Örebro, Sweden; Karolinska Institute, Stockholm, Sweden
show less...
 (creator_code:org_t)
Oxford, United Kingdom : Elsevier, 2001
2001
English.
In: Leukemia Research. - Oxford, United Kingdom : Elsevier. - 0145-2126 .- 1873-5835. ; 25:11, s. 961-966
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Topoisomerase IIalpha (topoII alpha) is the target enzyme for several antineoplastic drugs. Correlation between low expression of topo IIalpha and drug resistance has been shown in vitro, but there is limited evidence of a correlation to initial response to treatment or to overall prognosis. Normal cells express topo IIalpha in S/G2/M phase of the cell cycle but not in G0/G1 phase. However, some data suggest that topo IIalpha could be expressed in G0/G1 phase in malignant cells. We have investigated the expression of topo IIalpha in leukemic cells from 25 patients with acute leukemia by flow cytometry, separating cells of different cell cycle phases. We demonstrated that 9/25 samples showed >50% positive cells in G0/G1, and another five samples showed >20%. This finding could possibly provide an explanation to previous difficulties in correlating topo IIalpha expression with clinical outcome. Six of eight patients, where >20% of the cells in G0/G1 were positive for topo IIalpha, entered CR, compared to one of five patients with <20% topo IIalpha positive cells in G0/G1. We suggest that topo IIalpha expression in G0/G1 in leukemic cells may be of predictive value for clinical response to cytostatic drugs.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)

Keyword

Acute leukemia
topoisomerase IIalpha
drug resistance
flow cytometry
cell cycle

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view